Heroin is an opioid agonist commonly abused for its rewarding effects. Since its synthesis at the end of the nineteenth century, its popularity as a recreational drug has ebbed and flowed. In the last three decades, heroin use has increased again, and yet the pharmacology of heroin is still poorly understood. After entering the body, heroin is rapidly deacetylated to 6-monoacetylmorphine (6-MAM), which is then deacetylated to morphine. Thus, drug addiction literature has long settled on the notion that heroin is little more than a pro-drug. In contrast to these former views, we will argue for a more complex interplay among heroin and its active metabolites: 6-MAM, morphine, and morphine-6-glucuronide (M6G). In particular, we propose that the complex temporal pattern of heroin effects results from the sequential, only partially overlapping, actions not only of 6-MAM, morphine, and M6G, but also of heroin per se, which, therefore, should not be seen as a mere brain-delivery system for its active metabolites. We will first review the literature concerning the pharmacokinetics and pharmacodynamics of heroin and its metabolites, then examine their neural and behavioral effects, and finally discuss the possible implications of these data for a better understanding of opioid reward and heroin addiction. By so doing we hope to highlight research topics to be investigated by future clinical and pre-clinical studies.
28 September 2021 in Neuroscience & Biobehavioral Reviews
Background and Purpose: Studies using intermittent‐access drug self‐administration show increased motivation to take and seek cocaine and fentanyl, relative to continuous access. In this study, we examined the effects of intermittent‐ and continuous‐access self‐administration on heroin intake, patterns of self‐administration and cue‐induced heroin‐seeking, after forced or voluntary abstinence, in male and female rats. We also modelled brain levels of heroin and its active metabolites.Experimental Approach: Rats were trained to self‐administer a palatable solution and then heroin (0.075 mg·kg−1 per inf) either continuously (6 h·day−1; 10 days) or intermittently (6 h·day−1; 5‐min access every 30‐min; 10 days). Brain levels of heroin and its metabolites were modelled using a pharmacokinetic software. Next, heroin‐seeking was assessed after 1 or 21 abstinence days. Between tests, rats underwent either forced or voluntary abstinence. The oestrous cycle was measured using a vaginal smear test.Key Results: Intermittent access exacerbated heroin self‐administration and was characterized by a burst‐like intake, yielding higher brain peaks of heroin and 6‐monoacetylmorphine concentrations. Moreover, intermittent access increased cue‐induced heroin‐seeking during early, but not late abstinence. Heroin‐seeking was higher in females after intermittent, but not continuous access, and this effect was independent of the oestrous cycle.Conclusions and Implications: Intermittent heroin access in rats resembles critical features of heroin use disorder: a self‐administration pattern characterized by repeated large doses of heroin and higher relapse vulnerability during early abstinence. This has significant implications for refining animal models of substance use disorder and for better understanding of the neuroadaptations responsible for this disorder.LINKED ARTICLES: This article is part of a themed issue on Advances in Opioid Pharmacology at the Time of the Opioid Epidemic. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v180.7/issuetoc
Background and Purpose: In some individuals, opioid use leads to decreased interest in socially relevant rewards. Recent studies showed that after extended‐access heroin self‐administration, rats strongly prefer social interaction over single unit‐dose heroin infusions. We hypothesized that this strong social preference results from access to a suboptimal heroin dose during testing, and individual differences in heroin versus social choice would emerge if rats were given access to their ‘preferred’ heroin dose. Experimental Approach: In Experiment 1, we trained male rats to lever‐press for social interaction, followed by heroin self‐administration under continuous‐access, no‐timeout schedule, which promotes burst‐patterned heroin taking. We then tested the rats for choice between single‐unit heroin dose and 1‐min full‐contact social interaction, or 5‐min heroin‐access (sufficient for burst‐patterned heroin taking) and 5‐min social interaction. In Experiment 2, we extended the 5‐min access procedure to female rats and tested heroin versus limited‐contact (screen‐based) social interaction. We also manipulated response requirements (effort) for heroin. Key Results: Rats given a single‐unit heroin dose during choice testing, strongly preferred social interaction. In rats given 5‐min heroin‐access, large individual differences in heroin preference emerged. These differences were independent of sex, social‐interaction conditions and effort manipulations. High heroin intake and burst‐patterned heroin taking during self‐administration, and high heroin seeking during abstinence predicted individual differences in heroin preference. Conclusion and Implications: Access to ‘preferred’ heroin doses during the choice tests leads to stable and effort‐independent individual differences in heroin preference. This procedure provides a platform to study mechanisms of resilience and vulnerability to opioid addiction.
Background and Purpose: Heroin and cocaine users tailor their dosage, frequency and administration route to maximise the drugs' effects or prevent withdrawal symptoms. Counterintuitively, preclinical self‐administration and choice experiments employ, almost invariably and regardless of the pharmacokinetic properties of the drug under examination, fixed unit‐doses and timeouts (after unit‐doses) largely resulting in uniform drug‐taking patterns. This uniformity contrasts with the large variability observed in humans, which serves as critical indicator of addiction severity and treatment success. Here, by combining behavioural and pharmacokinetics assessments, we revealed that drug self‐administration procedures without timeouts may overcome this limitation.Experimental Approach: We analysed heroin‐ and cocaine‐taking patterns and seeking and estimated drug‐brain levels in the presence or absence of timeout under different training conditions.Key Results: Removing timeouts had a profound effect on heroin‐taking patterns and seeking, promoting the emergence of burst‐like intake, yielding higher brain peak concentrations of heroin. In contrast, the removal of timeout had marginal impact on cocaine‐taking patterns and seeking.Conclusion and Implications: The removal of timeout during self‐administration revealed distinct cocaine and heroin patterns, with the latter closely resembling human heroin use patterns.
Neuropathic pain (NP) originates from an injury or disease of the somatosensory nervous system. This heterogeneous origin and the possible association with other pathologies make the management of NP a real challenge. To date, there are no satisfactory treatments for this type of chronic pain. Even strong opioids, the gold-standard analgesics for nociceptive and cancer pain, display low efficacy and the paradoxical ability to exacerbate pain sensitivity in NP patients. Mounting evidence suggests that chemokine upregulation may be a common mechanism driving NP pathophysiology and chronic opioid use-related consequences (analgesic tolerance and hyperalgesia). Here, we first review preclinical studies on the role of chemokines and chemokine receptors in the development and maintenance of NP. Second, we examine the change in chemokine expression following chronic opioid use and the crosstalk between chemokine and opioid receptors. Then, we examine the effects of inhibiting specific chemokines or chemokine receptors as a strategy to increase opioid efficacy in NP. We conclude that strong opioids, along with drugs that block specific chemokine/chemokine receptor axis, might be the right compromise for a favorable risk/benefit ratio in NP management.